Labo’Life’s micro-immunotherapy medicines are designed to regulate the immune system response in a specific way, with the objective of helping it to restore and/or maintain its correct functioning.
Below you will find a collection of frequently asked questions about our medicines.
The most frequently asked questions are marked with the symbol
Yes. Labo’Life’s formulas are medicines. Their commercialisation is authorised by the different pharmaceutical legislations in the countries where they are produced and distributed. Furthermore, Labo’Life’s medicines are only available in pharmacies.
Micro-immunotherapy medicines made by Labo’Life’s laboratory are medicines for human use which fall into the category of homeopathic medicines with regard to their manufacturing process, and use active substances (raw materials) of an immunological nature.
Labo’Life’s micro-immunotherapy medicines are distributed exclusively in pharmacies and are not available in shops.
Current law prohibits their direct sale to private individuals. Pharmaceutical companies can only supply wholesalers and pharmacies. This means that unless you are a pharmacy, you cannot order your medicines directly from Labo’Life.
Any pharmacy can contact us directly via our order service. To avoid any possible misunderstanding, we will require written confirmation.
In accordance to the current pharmaceutical legislation, Labo’Life’s products include both registered medicines with a therapeutic indication and notified medicines with no official therapeutic indication. Some of these medicines are available only on medical prescription in Belgium. However, as Labo'Life's micro-immunotherapy treatments are very specific, it is advisable to consult a doctor trained in micro-immunotherapy to ensure that you receive the most appropriate treatment for your condition. Your pharmacist can also provide advice concerning most of our treatments.
Labo'Life treatments are marketed under the authorization of the competent medicine agencies. In accordance with current pharmaceutical legislation, Labo’Life’s products include both registered medicines with a therapeutic indication and notified medicines with no official therapeutic indication.
Registered medicines with a therapeutic indication must be supplied with an information leaflet specifying their respective therapeutic indication. By contrast, the domains of use for notified medicines with no official indication depend on the properties and dilutions of their components and are defined, along with the dose to be used, by the prescriber. Current regulations do not specify an obligation to include instruction leaflets in the packaging of such medicines. However, Labo'Life has decided to include an instruction leaflet, to provide patients with as much information as possible.
The active substances used in our medicines are present in small doses, which means they cause very few side effects.
Labo’Life’s micro-immunotherapy medicines, like other medicines, contain a small amount of lactose in the granules. In some cases, patients who cannot tolerate this type of sugar can suffer digestive problems after taking the medicine on an empty stomach.
To give you an idea, the granules from a capsule can contain a quantity of lactose 100 times lower than the one contained in half a glass of milk. A lactose intolerant person can therefore try to take this medicine and see if they can tolerate it. If not, many prescribing doctors advise systematically delaying taking the medicine until 1 hour after meals. If you still have problems, they also advise dissolving the granules in a glass with a small amount of mineral water and then afterwards let the water remain in contact with the sublingual mucosa for as long as possible.
When the immune system reacts to the treatment, symptoms may intensify, which is normal during the first 2 weeks of treatment. If the symptoms are tolerable and allow you to keep taking the treatment, it is best to continue taking the medicines: the symptoms will gradually disappear. If the symptoms are very severe or persistent, contact your doctor.
The medicines are contraindicated if there is any known hypersensitivity to any of the active substances or any of the excipients contained in the medicine. If you suffer from any intolerance or allergy, consult your doctor before taking the medicine.
No. If you are taking another treatment, only your doctor can decide when you should stop taking it. You should never, under any circumstances, decide for yourself to stop taking any other treatment because you are taking a micro-immunotherapy medicine.
Micro-immunotherapy can be incorporated into a therapeutic strategy adapted to the patient, and therefore provides a complement to conventional therapies such as surgery, chemotherapy, etc., but should on no account substitute these.
Micro-immunotherapy medicines should be stored at room temperature, protected from light and moisture. It is not advisable to keep them, for example, in the bathroom.
It is likewise unadvisable to keep them near a source of electromagnetic waves, such as a microwave or mobile phones, among other things.
See "Medicine production" Section.
The immunological active substances we use are made according to biotechnology techniques. None of the active substances are therefore of human origin. When the production process allows it, the active substances are made without any additives from animal origin. These different points help guarantee the viral safety of our medicines. All the active substances have a certificate of analysis from the producer and are analysed by the Labo’Life’s Quality Control laboratories before being used in our medicines, in order to guarantee their pharmaceutical quality.
More information on micro-immunotherapy, how it acts on the body and its differences from classic immunotherapy can be found here: What is micro-immunotherapy?